Solid Cancer Genomic testing

Solid cancer clinical indications are included in both the Rare Disease and Cancer National Genomics Test Directories as follows:

Solid cancer clinical indications

NHSE National Genomics Test Directory

Clinical Indication Category

Link for further details

Rare Disease

Inherited Cancer

(22 clinical indications)

More details on rare disease testing

 

Endocrinology

(4 clinical indications)

 

 

Neurology

(3 clinical indications)

 

Cancer

Adult Solid Tumours

(29 clinical indications)

More details on adult solid tumours

 

Neurological

(31 clinical indications)

More details on neurolgical tumours 

 

Paediatric

(46 clinical indications)

Also eligible for WGS

More details on paediatric tumours

More details on whole genome sequencing

 

Sarcoma

(54 clinical indications)

Also eligible for WGS

More details on sarcoma

More details on whole genome sequencing

WMRGL provides both germline and somatic genetic testing as appropriate according to current NHSE eligibility criteria [1] and [2].

Please refer to the relevant Clinical Indication Category link for details of which local, regional and national testing services are provided by WMRGL.

References

[1] https://www.england.nhs.uk/wp-content/uploads/2018/08/Rare-and-Inherited-Disease-Eligibility-Criteria-November-2020-21.pdf

[2] https://www.england.nhs.uk/wp-content/uploads/2018/08/National-Genomic-Test-Directory-Cancer-November-2020-21.xlsx